The PSI 2021 conference was held online due to the COVID-19 (coronavirus) pandemic.
The conference ran over three full days and consisted of a variety of live plenary and parallel sessions, additional on demand content, breakout discussion sessions, workshops, posters and virtual exhibitor stands. The conference also incorporated interactive and sociable elements to try to recreate those aspects we know people love about the PSI Conference.
The PSI Scientific Committee worked hard creating an exciting and relevant program. The resulting conference was a great success, having a record number of attendees and we received lots of positive feedback.
Content from the conference, including recordings of the majority of the live sessions, will remain accessible within the platform for all registered delegates until the end of December 2021 giving delegates the opportunity to catch up on what they missed, or re-watch a favourite session. The 2021 Online Cinference content is accessible for PSI members on the Video On Demand section of this website.
Paul Terrill, 2021 PSI Conference Chair
David Lawrence, 2021 PSI Conference Vice-Chair
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
